0

524400

ISHITADR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ISHITA DRUGS & INDUSTRIES LTD. Share Price Today

Investment Returns

Over 1 Month -10.44% Over 3 Months -6.96% Over 6 Months -6.31% Over 1 Year -3.21%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ISHITA DRUGS & INDUSTRIES LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 21.20
  • P/E Ratio (TTM) 27.21
  • Beta 0.70
  • Book Value / share 38.69
  • Return on equity 8.40%
  • EPS (TTM) 2.60
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.18
info icon alternate text

ISHITA DRUGS & INDUSTRIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 3.06
Operating Expense 3.00
Net Profit 0.18
Net Profit Margin (%) 5.88
Earnings Per Share (EPS) 0.59
EBITDA 0.32
Effective Tax Rate (%) 35.71
Particulars DEC 2025 (Values in Cr)
Revenue 3.14
Operating Expense 3.05
Net Profit 0.16
Net Profit Margin (%) 5.09
Earnings Per Share (EPS) 0.52
EBITDA 0.24
Effective Tax Rate (%) 21.05
Particulars SEP 2025 (Values in Cr)
Revenue 3.07
Operating Expense 2.91
Net Profit 0.14
Net Profit Margin (%) 4.56
Earnings Per Share (EPS) 0.48
EBITDA 0.25
Effective Tax Rate (%) 36.36
Particulars JUN 2025 (Values in Cr)
Revenue 5.40
Operating Expense 5.10
Net Profit 0.30
Net Profit Margin (%) 5.55
Earnings Per Share (EPS) 1.01
EBITDA 0.44
Effective Tax Rate (%) 23.07
Particulars MAR 2025 (Values in Cr)
Revenue 4.56
Operating Expense 4.34
Net Profit 0.29
Net Profit Margin (%) 6.35
Earnings Per Share (EPS) 0.96
EBITDA 0.44
Effective Tax Rate (%) 23.68
Particulars MAR 2026 (Values in Cr)
Revenue 14.66
Operating Expense 14.05
Net Profit 0.78
Net Profit Margin (%) 5.32
Earnings Per Share (EPS) 2.60
EBITDA 1.24
Effective Tax Rate (%) 27.77
Particulars MAR 2025 (Values in Cr)
Revenue 15.00
Operating Expense 14.18
Net Profit 0.87
Net Profit Margin (%) 5.80
Earnings Per Share (EPS) 2.90
EBITDA 1.34
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 15.19
Operating Expense 14.48
Net Profit 0.75
Net Profit Margin (%) 4.93
Earnings Per Share (EPS) 2.50
EBITDA 1.19
Effective Tax Rate (%) 24.24
Particulars MAR 2023 (Values in Cr)
Revenue 12.07
Operating Expense 11.49
Net Profit 0.58
Net Profit Margin (%) 4.80
Earnings Per Share (EPS) 1.93
EBITDA 0.96
Effective Tax Rate (%) 25.64
Particulars MAR 2022 (Values in Cr)
Revenue 14.09
Operating Expense 13.15
Net Profit 0.81
Net Profit Margin (%) 5.74
Earnings Per Share (EPS) 2.69
EBITDA 1.19
Effective Tax Rate (%) 23.07
Particulars MAR 2025 (Values in Cr)
Book Value / Share 36.08
ROE % 8.40
ROCE % 10.00
Total Debt to Total Equity 0.19
EBITDA Margin 8.87
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.18
ROE % 7.86
ROCE % 10.77
Total Debt to Total Equity 0.05
EBITDA Margin 7.83
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.68
ROE % 6.53
ROCE % 8.86
Total Debt to Total Equity 0.05
EBITDA Margin 7.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 28.75
ROE % 9.76
ROCE % 12.90
Total Debt to Total Equity 0.00
EBITDA Margin 8.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 26.05
ROE % 11.25
ROCE % 14.32
Total Debt to Total Equity 0.02
EBITDA Margin 8.82
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.83
Total Assets 16.29
Total Liabilities 16.29
Total Equity 10.78
Share Outstanding 0
Price to Book Ratio 2.18
Return on Assets (%) 5.32
Return on Capital (%) 5.91
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.80
Total Assets 10.80
Total Liabilities 10.80
Total Equity 9.92
Share Outstanding 0
Price to Book Ratio 1.98
Return on Assets (%) 6.92
Return on Capital (%) 7.54
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.42
Total Assets 11.40
Total Liabilities 11.40
Total Equity 9.17
Share Outstanding 0
Price to Book Ratio 1.61
Return on Assets (%) 5.06
Return on Capital (%) 5.7
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.68
Total Assets 11.25
Total Liabilities 11.25
Total Equity 8.59
Share Outstanding 0
Price to Book Ratio 1.44
Return on Assets (%) 7.15
Return on Capital (%) 9.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.53
Total Assets 9.26
Total Liabilities 9.26
Total Equity 7.79
Share Outstanding 0
Price to Book Ratio 1.15
Return on Assets (%) 8.95
Return on Capital (%) 10.65
Particulars MAR 2025 (Values in Cr)
Net Income 1.15
Cash from Operations -3.63
Cash from Investing -0.66
Cash from Financing 4.32
Net change in Cash 0.02
Free Cash Flow -3.45
Particulars MAR 2024 (Values in Cr)
Net Income 0.98
Cash from Operations 2.12
Cash from Investing 0.13
Cash from Financing -0.86
Net change in Cash 1.38
Free Cash Flow 2.14
Particulars MAR 2023 (Values in Cr)
Net Income 0.77
Cash from Operations -2.89
Cash from Investing 0.59
Cash from Financing 1.04
Net change in Cash -1.25
Free Cash Flow -2.76
Particulars MAR 2022 (Values in Cr)
Net Income 1.04
Cash from Operations 3.07
Cash from Investing -0.93
Cash from Financing 0.00
Net change in Cash 2.14
Free Cash Flow 3.09
Particulars MAR 2021 (Values in Cr)
Net Income 1.05
Cash from Operations -0.67
Cash from Investing 2.45
Cash from Financing -0.23
Net change in Cash 1.53
Free Cash Flow -0.66
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LTD. 338.20 14.92 2.44 995.36 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2332.85 41.07 17.42 39519.89 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTAJAN HEALTH LTD 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

ISHITA DRUGS & INDUSTRIES LTD. shareholding pattern

Holding
49.96%
50.03%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ISHITA DRUGS & INDUSTRIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
70.75 -5.66 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 73.40
  • 26 Days 76.60
  • 10 Days 74.70
  • 50 Days 77.00
  • 12 Days 75.10
  • 100 Days 76.40
  • 20 Days 76.20
  • 200 Days 76.10
74.17 PIVOT
First Support 73.33 First Resistance 75.83 Second Support 71.67 Second Resistance 76.67 Third Support 70.83 Third Resistance 78.33
RSI 40.38 ADX 15.00 MACD -1.50 Williams % R -100.00 Commodity Channel Index (CCI) -144.61
Date 2026-06-19 Week 525.00 Same Day 508.00 Month 916.00
1 Year 0.71 3 Year 0.48
Over 1 Month
-10.44% down
Over 1 Year
-3.21% down
Over 3 Months
-6.96% down
Over 3 Years
6.84% down
Over 6 Months
-6.31% down
Over 5 Years
19.81% down

ISHITA DRUGS & INDUSTRIES LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Ishita Drugs & Industries Ltd?

Answer Field

Ishita Drugs & Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 70.75 as on Jun 19 2026 03:11 PM.

What is the Market Cap of Ishita Drugs & Industries Ltd Share?

Answer Field

The market cap of Ishita Drugs & Industries Ltd for NSE ₹ 0.00 & for BSE ₹ 21.20 as on Jun 19 2026 03:11 PM.

What is the 52 Week High and Low of Ishita Drugs & Industries Ltd?

Answer Field

The 52 Week High and Low of Ishita Drugs & Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 90.85 and ₹ 66.00.

What is 1 year return for Ishita Drugs & Industries Ltd?

Answer Field

The 1 year returns on the stock has been -3.21%.

What is the P/E Ratio of Ishita Drugs & Industries Ltd Share?

Answer Field

As on Jun 19 2026 03:11 PM the price-to-earnings (PE) ratio for Ishita Drugs & Industries Ltd share is 27.21.

What is the PB ratio of Ishita Drugs & Industries Ltd Share?

Answer Field

As on Jun 19 2026 03:11 PM, the price-to-book (PB) ratio for Ishita Drugs & Industries Ltd share is 38.69.

How to Buy Ishita Drugs & Industries Ltd Share?

Answer Field

You can trade in Ishita Drugs & Industries Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ishita Drugs & Industries Ltd Share on Bajaj Broking App?

Answer Field

To buy Ishita Drugs & Industries Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ishita Drugs & Industries Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|